- Home
- applications
- france
- healthcare cloud development enablement services
Healthcare Cloud Development Enablement Services Product Applications In France
15 applications found
Endometriosis affects 10% of all women of reproductive age. Endometriosis is caused by tissue that usually lines inside the uterus developing outside the uterus. It is a chronic and complex disorder, affecting 10% of all women of reproductive age, and up to 40% of all women with infertility, representing an estimated 180 million patients ...
ByEndodiag based in Paris, FRANCE
Patients with endometriosis present with a variety of symptoms, most notably chronic pelvic pain (75% of patients) and infertility (up to 40%). Common signs of endometriosis include painful menstrual cramps, pain during or after sexual intercourse, pain in the intestine or lower abdomen, painful urination, heavy menstrual periods, bleeding between periods, painful bladder syndrome, and chronic ...
ByEndodiag based in Paris, FRANCE
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. Localized prostate cancer can be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Indolent or aggressive, to treat or not to treat this cancer? This is always the question urologists ask themselves. ...
ByOncoDiag based in Miserey, FRANCE
When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health. ...
ByQynapse based in Paris, FRANCE
Comprehensive Imaging Solution for the Management of Breast Cancer Patients. SuperSonic Imagine has raised the bar in breast ...
BySupersonic Imagine based in Aix-en-Provence, FRANCE
AAA may be detected during a routine physical when feeling your abdomen, with a chest x-ray or ultrasound. ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
Following abdominal surgery, you may need a ventilator to help with your breathing. Once you can breathe on your own, you will be asked to cough occasionally to keep fluid from collecting in your lungs. You will have a drainage tube in your stomach and will not be able to eat or drink until it is removed, usually a few days after the procedure. Gradually you will be able to get out of bed, walk, and return to eating solid foods. Recovery from abdominal surgical repair takes approximately 3 months and will require ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
After an EVAR or PEVAR procedure, you will be given pain medication if needed and will be able to gradually get out of bed, walk, and eat solid foods. You may feel well enough to resume your normal activities in 4 to 6 weeks. Endovascular repair means you will need regular follow up visits with your doctor: a month afterward, at six months, and each year following your procedure. The visits will include a physical exam and an ultrasound, CT scan, or angiography to check for any ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
Endovascular Aneurysm Repair (EVAR) is a minimally invasive procedure that accesses the aorta through a small incision in your groin. Thin wires are inserted through the femoral arteries and act as a guide for a long, thin tube called a catheter. A stent is delivered through the catheter to the site of the aneurysm and expands to reinforce the damaged portion of the aorta. The wire and catheter will be removed, the doctor will confirm that the stent is in the proper position, and the incision will be closed with a ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
IMMUNOSCORE® IC is intended for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Regular Examinations with ultrasounds (if AAA is less than 5 cm) to monitor the condition. Abdominal Surgery (also called Open Repair) is performed under general anesthesia to access the aorta through an incision in your abdomen. The damaged section of the aorta is removed and a fabric tube called a graft is stitched in its place. The surgery usually takes 2-4 hours and requires a hospital stay of 5-7 days. Your recovery may take 3 months or ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
Percutaneous Endovascular Aneurysm Repair (PEVAR) accesses your femoral artery through a small puncture in your groin area. Thin wires are inserted through the femoral arteries and act as a guide for a long, thin tube called a catheter. A stent is delivered through the catheter to the site of the aneurysm and expands to reinforce the damaged portion of the aorta. The wire and catheter will be removed. The doctor will confirm that the stent is in the proper position and pressure will be applied to the puncture site ...
ByEndologix LLC based in Irvine, CALIFORNIA (USA)
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Bladder cancer is the seventh most common cancer diagnosis in worldwide, with 500 000 new cases and 200 000 deaths in 2018 (Globocan 2018). More than 2.7 million people have a history of bladder cancer worldwide. At the initial diagnosis of bladder cancer, more than 80% of cases are diagnosed as non-muscle-invasive bladder cancer (NMIBC). Due to the very high recurrence rate (>80%), NMIBC patients require lifelong surveillance with periodic follow-up cystoscopy (an unpleasant invasive exam) and urine cytology ...
ByOncoDiag based in Miserey, FRANCE